Preclinical efficacy and safety of an anti-IL-1β vaccine for the treatment of type 2 diabetes

Por Gunther Spohn, Christian Schori, Iris Keller, Katja Sladko, Christina Sina, Reto Guler, Katrin Schwarz, Pål Johansen, Gary T Jennings, Martin F Bachmann
Publicado em 2014-01-01